Company: ZURA
Filing Date: 2025-10-10
Form Type: 8-K
Source: 0001104659-25-098546
Chunk: 0

Company: Zura Bio Ltd
Filing Date: 2025-10-10
Form: 8-K
Item: Item 5.02
Chunk 0
---
Item 5.02 Departure of Directors or Certain
Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On October 8, 2025, Robert Lisicki, Chief
Executive Officer (principal executive officer) and member of the Board of Directors of Zura Bio Limited (the “ Company”)
informed the Company that he is taking a medical leave of absence, effective October 10, 2025. Accordingly, effective October
10, 2025, the Company’s Board of Directors appointed Kim Davis, Chief Operating Officer, Chief Legal Officer and Corporate
Secretary, to serve as the Company’s interim Chief Executive Officer and interim principal executive officer, in
addition to her current duties.

Biographical and other information for Ms. Davis
is set forth in the Company’s definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on April
23, 2025 and is incorporated herein by reference. Ms. Davis is not party to any arrangement or understanding pursuant to which she was
appointed as an officer, nor is she party to any transactions required to be disclosed pursuant to Item 404(a) of Regulation
S-K. There are no family relationships between Ms. Davis and any of the Company’s directors or executive officers.

SIGNATURES

Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.

                              ZURA BIO LIMITED                                                                                                             
  Date: October 10, 2025      By:                   /s/ Kim Davis                                                                                          
                                                    Kim Davis                                                                                              
                                                    Interim Chief Executive Officer, Chief Operating Officer, Chief Legal Officer and Corporate Secretary